Telmisartan Compared With Enalapril in Elderly Patients With Blood Hypertension
NCT02177461 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 374
Last updated 2014-07-08
Summary
Study to assess the efficacy and tolerability of Telmisartan 40-80 mg once daily compared with enalapril 10-20 mg once daily in elderly patients with arterial hypertension.
Conditions
Interventions
- DRUG
-
Telmisartan
- DRUG
-
Enalapril
- DRUG
-
Clonidine
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-04-30
- Primary Completion
- 2002-08-31
More Related Trials
-
PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)
NCT00274638 ·Status: COMPLETED ·Phase: PHASE4
-
Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension
NCT02183701 ·Status: COMPLETED ·Phase: PHASE3
-
Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes
NCT00240422 ·Status: COMPLETED ·Phase: PHASE4
-
Natriuretic Effect of Telmisartan Versus Placebo in Patients With Mild-to-Moderate Hypertension
NCT02176499 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Telmisartan and Losartan in Primary Hypertension
NCT02269176 ·Status: COMPLETED ·Phase: PHASE3
-
Filtered Trial for Telmisartan 40mg Non-responder
NCT00550953 ·Status: COMPLETED ·Phase: PHASE3
-
Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension
NCT00558428 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination
NCT00618774 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
NCT00153101 ·Status: COMPLETED ·Phase: PHASE4
-
BIBR 277 Capsule in Patients With Essential Hypertension
NCT02177448 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension
NCT00257491 ·Status: COMPLETED ·Phase: PHASE3
-
TElmisartan and AMlodipine Single Pill sTudy With Patients Not on Goal With Mono rAas Therapy-switch
NCT01134393 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension (ATHOS Study)
NCT00240474 ·Status: COMPLETED ·Phase: PHASE4
-
Tolerability and Pharmacokinetics of Telmisartan in Combination With Lacidipine in Healthy Male Subjects
NCT02218684 ·Status: COMPLETED ·Phase: PHASE1
-
Trial of Telmisartan 80 mg/HCTZ 12.5 mg and Telmisartan 40 mg/HCTZ 12.5 mg in Patients With Hypertension
NCT00326768 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure Rise
NCT00946829 ·Status: COMPLETED
-
Safety Evaluation of Telmisartan Plus Hydrochlorothiazide in Patients With Mild-to-Moderate Hypertension
NCT02177487 ·Status: COMPLETED ·Phase: PHASE3
-
Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension
NCT00281580 ·Status: COMPLETED ·Phase: PHASE3
-
26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension
NCT00624052 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled
NCT02526875 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with Essential Hypertension
NCT06282549 ·Status: ACTIVE_NOT_RECRUITING
-
S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension
NCT03226340 ·Status: UNKNOWN ·Phase: PHASE4
-
Filtered Trial for Amlodipine Non-responder
NCT00558064 ·Status: COMPLETED ·Phase: PHASE3
-
Survey to Assess Why People Are Not Responding to Treatment in Hypertension
NCT01071681 ·Status: COMPLETED
-
Telmisartan+Amlodipine Fixed Dose Combination in Hypertension
NCT01204398 ·Status: COMPLETED ·Phase: PHASE3